UNEXPLAINED MOVE · MON NOV 2 2026

Why CERS rose 17.1% on Nov 2 2026: phase 3 endpoint

CERS+17.1%on Mon Nov 2 2026

Cerus Corp was up 17.1% on the day at $2.67, ranked #22 on 2.0× its usual five-minute volume, when TapeRank recorded this unexplained move at 16:01 ET during after hours.

THE DAY ON THE LIST · 1 EVENT

  1. 16:01 ET
    UNEXPLAINED MOVE · AFTER-HOURS

    $2.67 · ▲ 17.1% ON THE DAY · 2.0× 5M RVOL · RANK #22

    JUSTIFIEDCONFIDENCE5/5

    Cerus rose 15.6% on the day and accelerated 11.65% in five minutes after announcing that its Phase 3 RedeS trial met the primary endpoint. A successful Phase 3 endpoint supporting non-inferiority and a regulatory path for its core blood-product technology is a concrete, material catalyst that supports the move.

    WHYA 15.6% move, including an 11.65% five-minute surge, is substantial but proportionate to a positive Phase 3 primary-endpoint result with stated regulatory significance.
    ANALYZED 16:03 ET · <1 MIN AGO · OPENAI/GPT-5.6-LUNA
    THE ROW AND SESSION LEVELS AT 16:01 ET
    LAST2.67
    DAY▲ 17.1%
    5 MIN▲ 13.14%
    5M RVOL2.0×
    5M $VOL$577K
    FLOAT*201.5M
    RANK#22
    SESSIONAFTER-HOURS
    VWAP2.37
    HOD2.67
    LOD2.29
    OR HIGH2.34
    OR LOW2.29
    PREV CLOSE2.28
    PM HIGH2.32
    PM LOW2.32
    GAP▲ 1.75%

    * FLOAT IS SHARES OUTSTANDING; TRUE FREE FLOAT IS NOT AVAILABLE

THE SESSION

  • 09:30 ETOpened at $2.32, +1.8% on the previous close of $2.28
  • 09:30 ETRegular-session low, $2.29
  • 14:11 ETRegular-session high, $2.42
  • 15:59 ETLast trade of the regular session, $2.33, +2.2% on the previous close of $2.28
  • Volume: 2.2M shares in regular hours, 1K before the open

CERS opened at $2.32 and briefly touched $2.29 before climbing to $2.42 at 14:11 ET, then eased to $2.33 by the regular-session close, still above the previous close of $2.28. TapeRank later recorded the stock at $2.67 at 16:01 ET and read the move as justified, tying it to Cerus announcing that its Phase 3 RedeS trial met its primary endpoint, supporting non-inferiority and a regulatory path for its core blood-product technology; TapeRank noted an 11.65% five-minute acceleration. There were no halts, and no filings or news had appeared in the prior 24 hours.

WRITTEN MON NOV 2 2026 20:00 ET BY OPENAI/GPT-5.6-LUNA FROM THE FACTS ON THIS PAGE

FILINGS AND NEWS · 24H BEFORE THE MOVE

No SEC filings or wire news in the 24 hours before this was recorded. A move on news that never reached the wire shows nothing here, which is what UNEXPLAINED means.

On the tape right now

WHERE THE LIST STOODWED NOV 4 2026 · 13:49 ETRECORDED LIVE · 742 QUALIFY

01
ECGSURGING 0:05
79.71
▼ 29.3%
▼ 1.41%
41.0×
FAD
$6.2M
51.1M*
STRETCHED
02
CAVASURGING 0:00
64.78
▲ 7.4%
▲ 1.30%
9.3×
ORBHODVWH
$11.6M
116.8M*
UNEXPLAINED
03
URGNSURGING 0:00
29.16
▼ 15.2%
▼ 1.29%
15.6×
FAD
$1.4M
48.9M*
JUSTIFIED
04
MPTISURGING 0:00
64.15
▼ 1.5%
▲ 0.96%
23.8×
VWH
$637K
4.3M*
UNEXPLAINED
05
LSPDSURGING 0:00
11.52
▲ 4.9%
▼ 1.24%
16.5×
ORB
$426K
133.3M*
UNEXPLAINED
06
CRCTSURGING 0:00
8.90
▲ 49.2%
▼ 0.72%
15.1×
GAPORBVWHEXT
$395K
54.7M*
STRETCHED
07
BROSSURGING 0:00
43.97
▲ 0.9%
▼ 0.91%
4.0×
FAD
$4.3M
137.9M*
UNEXPLAINED
08
LMRICOOLING 1:35
12.85
▲ 14.5%
▲ 1.06%
132×
ORBHODVWH
$1.7M
—
UNEXPLAINED
Open the full list